Default: International Journal of Antimicrobial Agents

ISSN: 0924-8579

Journal Home

Journal Guideline

International Journal of Antimicrobial Agents Q1 Unclaimed

Elsevier Netherlands
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

International Journal of Antimicrobial Agents is a journal indexed in SJR in Medicine (miscellaneous) and Infectious Diseases with an H index of 130. It has an SJR impact factor of 1,454 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,454.

International Journal of Antimicrobial Agents focuses its scope in these topics and keywords: activity, isolates, factors, clinical, infection, care, klebsiella, falciparum, antibiotic, pneumoniae, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

International Journal of Antimicrobial Agents

1,454

SJR Impact factor

130

H Index

330

Total Docs (Last Year)

843

Total Docs (3 years)

11732

Total Refs

3619

Total Cites (3 years)

715

Citable Docs (3 years)

4,31

Cites/Doc (2 years)

35,55

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


activity, isolates, factors, clinical, infection, care, klebsiella, falciparum, antibiotic, pneumoniae, plasmodium, artemisinin, gene, extendedspectrum, exhibits, increases, intensive, selective, susceptibility, disseminated, enterobacteriaceae, experimental, ?lactamaseproducing,



Best articles by citations

Management of urinary tract infections in the nursing home elderly: a proposed algorithmic approach

View more

Rapid detection of methicillin resistance in staphylococci using a slide latex agglutination kit

View more

The role of the hospital nursing staff in home health-care services

View more

A multi-centre study of nosocomial methicillin-resistant Staphylococcus aureus in Greece

View more

Population pharmacokinetics of tobramycin in hospitalized patients receiving once-daily dosing regimen

View more

Rifampicin sub-inhibitory concentrations reduce the expression of haemolysin in Aeromonas spp.

View more

Streptococcus pneumoniae in Saudi Arabia: antibiotic resistance and serotypes of recent clinical isolates

View more

When to do culture in urinary tract infections

View more

Broad-spectrum beta-lactam antibiotics with beta-lactamase inhibitors

View more

Prevention and management of mucositis in patients with cancer

View more

Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit

View more

Modification of acquired immunity in BALB/c mice by aztreonam

View more
SHOW MORE ARTICLES

Antimicrobial resistance of Streptococcus pneumoniae, Haemophilius influenzae and Moraxella catarrhalis isolated in Hawaii

View more

Selective toxicity, side effects and resistance

View more

EU conference 'The Microbial Threat'

View more

Hepatosplenic candidiasis in non-neutropenic patients: a case report and literature survey

View more

Outpatient parenteral antibiotic therapy

View more

Urinary tract infections in HIV disease

View more

Comparative pharmacoeconomic study of vancomycin and teicoplanin in intensive care patients

View more

Influence of a prophylactic single dose of ciprofloxacin on the level of resistance of Escherichia coli to fluoroquinolones in urology

View more

Azithromycin: the first of the tissue-selective azalides

View more

Teicoplanin vs. vancomycin for the treatment of serious infections: a randomised trial

View more

Editorial

View more

HPLC determination of clofazimine in tissues and serum of mice after intravenous administration of nanocrystalline or liposomal formulations

View more

FAQS